Top navigation
Health & Wellness Physician Finder
Management of Palpable Breast Mass
Management of Congestive Heart Failure
Management of Diabetes Mellitus in Adults
Management of Hyperlipidemia
 
1. Contraindications and Precautions for Childhood Immunizations

2. Birth to 24 Months
3. Ages 2-6
4. Ages 7-12
5. Ages 13-18
6. Ages 19-39
7. Ages 40-64
8. Ages 65 and Over
9. Pregnant Women

   

Preventive Services Guidelines

Birth to 24 Months of Age

Schedule

At least four visits are required for immunizations: 2, 4, 6, and 12-18 months of age. Because of lack of data and differing patient risk profiles, the scheduling of additional visits and the frequency of the individual preventive services are left to clinical discretion (except as indicated). The preventive services are listed below.

DISCLAIMER: Coverage of preventive services varies under PPO and indemnity plans. Members covered under these policies need to refer to their Certificate of Coverage or contact a customer service representative for information regarding covered services.

Screening

  • Length and weight head circumference

    High Risk Groups:

  • Hearing [HR1] at age 18 months visit, if not tested earlier (Parental perception of hearing, awakes to loud noises, head turning with noise, repeats sounds, three to four words other than mama/dada, observational screening with noisemakers, and an ear exam including pneumatic otoscopy. Tympanometry is optional.)
  • Serum Lead [HR2] lead history age 9-15 months and level if appropriate
  • Hemoglobin OR hematocrit [HR6]

Immunizations and/or Chemoprophylaxis

  • Hepatitis B vaccine-at birth, 1-4 months and 6-18 months OR 0-2 months, 1-2 months later, and 6-18 months later
  • Diphtheria-tetanus-pertussis (DTP) vaccine-at ages 2, 4, 6, and 12-18 months
  • Measles-mumps-rubella (MMR)-at age 12-15 months
  • IPV at 2 and 4 months with OPV at 6-18 months (preferred) OR OPV-at ages 2, 4, and 6-18 months OR IPV at 2, 4, and 12 months
  • Hemophilus b Conjugated Vaccine (Hbc)-at ages 2, 4, 6, and 12-15 months
  • Varicella at 12-18 months

    High Risk Groups:

  • Fluoride supplements [HR3]
  • Influenza vaccine [HR5]

First Week:

  • Ophthalmic antibiotics-at birth
  • Hemoglobin electrophoresis or comparable test [HR4]-at birth
  • T4/TSH-days 3 to 6 preferred for testing (if done in hospital repeat at 7-14 days age)
  • Phenylalanine-days 3 to 6 preferred for testing (if done in hospital repeat at 7-14 days age)

Patient and/or Parent Counseling

Diet:

  • Breast-feeding
  • Nutrient intake, especially iron-rich foods Injury
  • Injury Prevention:
  • Child safety seats
  • Smoke detector
  • Carbon monoxide detector
  • Hot water heater temperature
  • Stairway gates, window guards, pool fences
  • Storage of drugs and toxic chemical
  • Syrup of ipecac or activated charcoal; poison control telephone number

    Dental Health:

  • Baby bottle tooth decay

    Other Primary Preventive Measures:

  • Effects of passive smoking

Remain Alert for:

  • Ocular misalignment
  • Tooth decay
  • Signs of child abuse or neglect

Leading Causes of Death:

  • Conditions originating in the perinatal period
  • Congenital anomalies
  • Sudden infant death syndrome (SIDS)
  • Unintentional injuries (non-motor vehicle)
  • Motor vehicle injuries

Definitions of High Risk Patients

These definitions apply to the category of Birth to 18 Months of Age only.

TERM DEFINITION

  • HR1: Infants with a family history of childhood hearing impairment or a personal history of congenital perinatal infection with herpes, syphilis, rubella, cytomegalovirus, or toxoplasmosis; malformations involving the head or neck (e.g. dysmorphic and syndromal abnormalities, cleft palate, abnormal pinna); birthweight below 1500 g; bacterial meningitis; hyperbilirubinemia requiring exchange transfusions; or severe perinatal asphyxia (Apgar scores of 0-3, absence of spontaneous respirations for 10 minutes or hypotonia at 2 hours of age).

  • HR2: Infants who live in or frequently visit housing built before 1960 that is dilapidated or undergoing renovation; who come in contact with other children with known lead toxicity; who live near lead processing plants or whose parents or household members work in a lead-related occupations; or who live near busy highways or hazardous waste sites.

  • HR3: Infants living in areas with inadequate water fluoridation (less than 0.6 parts per million).

  • HR4: Newborns of Caribbean, Latin American, Asian, Mediterranean, or African descent.

  • HR5: Residents of chronic care facilities or persons suffering from chronic cardiopulmonary disorders, metabolic diseases (including diabetes mellitus), hemoglobinopathies, immunosuppression, or renal dysfunction.

  • HR6: Infants age 6-12 mo. who are: living in poverty, African American, Native American or Alaska native, immigrants from developing countries, preterm or low birth weight, infants whose principal dietary intake is unfortified cow's milk.

< BackTopNext >